MUKILTEO, Wash., Feb. 10, 2009 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that preliminary data on its investigational Comprehensive Cancer Array test will be presented publicly for the first time, at Cambridge Healthtech Institute’s 16th International Molecular Medicine Tri-Conference being held on February 25-27, 2009, in San Francisco.
